BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Biotech Beach

  Halozyme Therapeutics, Inc. to Present at Two Upcoming Investor Conferences in March

  March 8, 2012

   · 

  1 min read
• Business

  Novavax, Inc. Appoints John A. Herrmann III, Vice President and General Counsel

  March 8, 2012

   · 

  1 min read
• Business

  NeurogesX, Inc. Reports Fourth Quarter and Year-End 2011 Results

  March 8, 2012

   · 

  1 min read
• BioForest

  Infectious Diseases Society of America Proposes New Pathway For Antibiotic Approval

  March 8, 2012

   · 

  2 min read
• Drug Development

  Michael E. DeBakey VA Medical Center Initiates Phase 2A Trial in Cancer Cachexia with AEterna Zentaris’ Ghrelin Agonist, AEZS-130

  March 8, 2012

   · 

  6 min read
• Business

  Unigene Laboratories, Inc. Announces Fourth Quarter and Full-Year 2011 Results

  March 8, 2012

   · 

  7 min read
• Genetown

  GI Dynamics Designates First EndoBarrier® Center of Excellence in Australia

  March 8, 2012

   · 

  5 min read
• Drug Development

  Ultragenyx Announces the Completion of the Phase 1 Clinical Study of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease

  March 8, 2012

   · 

  3 min read
• Drug Development

  Cytheris SA Announces Results of Phase II Study Indicating That Recombinant Interleukin-7 (CYT107) Expands CD4 T-Cells in Gut Mucosa of Chronically HIV Infected Immunological Non-Responder Patients

  March 8, 2012

   · 

  6 min read
• BioCapital

  Quotient Showcases ICHM3 Exploratory Clinical Trials at ASCPT

  March 8, 2012

   · 

  2 min read